How well-meaning donations end up fueling an unproven, virtually unregulated $2 billion stem cell industry

Quick Read

Big pharma is partnering with influencers to sell new drugs and medical devices

Quick Read

Imagine there was a store where there were no prices on items, and you never knew what you’d pay until you’d picked out your purchases and were leaving the shop. You might be skeptical that the store would have any incentive to offer reasonable prices

Quick Read

Left untreated, this viral disease can cause serious and costly health problems. Once a difficult-to-treat infection, chronic hepatitis C can now be cured by taking a regimen of daily pills for eight to 12 weeks that act directly against the virus. But there’s a hitch: This cure costs $25,000 or more per person

Quick Read

A HANDFUL OF years ago, a small pharmaceutical company quietly acquired the rights to an old but commonly used antibiotic. Few noticed until last week, when the new owner did something that’s recently become common in the world of pharmaceuticals: It abruptly raised the price. A lot

Quick Read

A 60-year-old antifungal drug called flucytosine that should cost a few dollars a day but is now vastly more expensive than that

Quick Read

Our Jeremy Greene, a professor of medicine at Johns Hopkins School of Medicine said that this was an important first step, but pointed out that shame, alone, may not be a powerful enough incentive to change behavior

Quick Read

Mr. Jones enters the pharmacy expecting to pick up his prescription. But when he gets to the window, he gets a rude awakening. His acne cream is $200, much too expensive for him to afford. What can doctors do about it?

Quick Read